3648 results for «2579»
3648 results
Advancing TAVI practice
21 May 2026 – From EuroPCR 2026
Advancing TAVI practice is the focus of this session, addressing antiplatelet therapy choices, novel transcatheter treatments for pure aortic regurgitation, early hemodynamic valve deterioration as a prognostic marker, prosthesis-patient mismatch in redo-TAVI, pioneering valve-in-mechanical valve interventions, and comprehensive core-lab evaluation of implantation depth and clinical outcomes.
Ambiguous left main lesions: how to assess severity and make the right decision
21 May 2026 – From EuroPCR 2026
Addressing the complexities of ambiguous left main coronary lesions, this session elucidates the integration of physiology, intracoronary imaging, and CT scanning for comprehensive assessment. It highlights multimodality diagnostic strategies and decision-making frameworks to guide appropriate revascularization.
TAVI procedural complications - Part 7: coronary protection, valve embolisation, and more
21 May 2026 – From EuroPCR 2026
This session addresses complex procedural complications in TAVI, featuring challenging cases such as rupture of the sinus of Valsalva, innovative bailouts for valve embolisation, mechanisms of aorta-right ventricular fistula post-TAVI, and management strategies for failed surgical aortic valves after endocarditis.
Inflammation and cardiovascular risk
21 May 2026 – From EuroPCR 2026
Exploring the interplay between inflammation and cardiovascular risk, this session reviews contemporary research on residual risk post-PCI, inflammatory markers in coronary artery disease especially in type 2 diabetes and ACS, and prognostic tools including lipoprotein(a) and systemic inflammation indices.
TAVI - Procedural strategy
21 May 2026 – From EuroPCR 2026
This session focuses on procedural strategies for TAVI, examining the influence of coronary artery disease severity on PCI decision-making, revascularisation approaches in high-bleeding risk patients, the role of CT imaging and implant depth in procedural planning, and comparative evaluation of pre-dilatation versus direct valve implantation in...
Modern risk prediction in TAVI
21 May 2026 – From EuroPCR 2026
This session examines modern risk prediction models in transcatheter aortic valve implantation (TAVI). It presents novel scoring systems, the prognostic significance of cardiac damage extent and progression, and the impact of multivalvular disease, enhancing patient stratification and outcome prediction.
Sealing the deal: catheter based solutions for aortic disease
21 May 2026 – From EuroPCR 2026
Examine catheter-based solutions for aortic disease management, featuring innovative approaches to preserving branch vessels, managing vascular complications, and repairing challenging aneurysms with endografts and occluders.
Imaging-guided calcified lesion PCI
21 May 2026 – From EuroPCR 2026
This session presents state-of-the-art imaging-guided interventions for calcified coronary lesions, showcasing modalities such as lithotripsy, rotational atherectomy, and complex calcium modification techniques. It includes case studies highlighting zero-contrast PCI and stenting in challenging anatomies, including left main bifurcation lesions in elderly patients with complex clinical backgrounds.
TAVI complications - Prediction, reduction, avoidance
21 May 2026 – From EuroPCR 2026
This session examines prediction, reduction, and avoidance of complications associated with TAVI procedures. It covers outcomes of second-valve implantation as a bail-out for valve migration, predictors of permanent pacemaker implantation post-TAVI from the LANDMARK trial, neurological event prognostics based on timing, and management of periprocedural cardiac...
Various NSTEMI cases
21 May 2026 – From EuroPCR 2026
This session presents diverse NSTEMI case studies addressing complex diagnostic and interventional challenges, including coronary dissections, intramural hematomas, ischemic complications, and functional lesion assessment.
CTO PCI: understand it, love it
21 May 2026 – From EuroPCR 2026
This educational session provides a comprehensive overview of chronic total occlusion (CTO) PCI, elucidating key procedural steps, essential materials, and potential complications. It highlights the significant role of nurses and allied health professionals in supporting the procedure and enhancing patient experience throughout the pre-, intra-, and...
Left main complications - Part 1
21 May 2026 – From EuroPCR 2026
Focus on managing complications related to left main coronary interventions, with detailed case analyses addressing procedural pitfalls, iatrogenic dissections, and unexpected imaging challenges.
Imaging evaluation in structural heart interventions
21 May 2026 – From EuroPCR 2026
This session offers a comprehensive evaluation of imaging techniques applied in structural heart interventions. It covers innovative studies including the impact of Dapagliflozin on multivalvular disease post-TAVI, advanced fusion methods combining CT and echocardiography to assess aortic stenosis severity, and the clinical relevance of the fibrocalcific...
Innovations in TAVI: TAVI 2.0
21 May 2026 – From EuroPCR 2026
This session presents cutting-edge advancements in transcatheter aortic valve implantation (TAVI), highlighting the TAVI 2.0 era. It encompasses innovative techniques such as percutaneous and non-fluoroscopic TAVR guided by transthoracic echocardiography (TTE), novel alternative access via the left subscapular approach, and patient-tailored commissural alignment assessed through CT...
New platforms for coronary lesions treatment
21 May 2026 – From EuroPCR 2026
Delve into the latest developments in coronary lesion treatment platforms through this session, highlighting real-world performance data of novel drug-eluting stents like Eternia and Evermine 50. It also presents preclinical insights on biomimetic CD31-coated stents, long-term outcomes of the Fantom BRS platform, and innovative randomized trials...
NSTEMI: when everything does not go as planned
21 May 2026 – From EuroPCR 2026
This session presents complex cases of NSTEMI where unexpected challenges arise during intervention. It provides a comprehensive review of complication management strategies, including coronary perforation techniques. Through detailed case analyses from diverse centers, attendees gain practical insights into troubleshooting and treatment adaptations essential for managing difficult...
Percutaneous management of mitral and aortic valve disease
21 May 2026 – From EuroPCR 2026
Delve into the percutaneous management of mitral and aortic valve disease through detailed procedural demonstrations. This session covers valve-in-valve procedures, navigation of potential complications in valve-in-valve TAVI, and mitral valve edge-to-edge repair techniques, supported by real-world case discussions and key learnings.
LAA closure and pulmonary embolism hotline
22 May 2026 – From EuroPCR 2026
Focusing on left atrial appendage (LAA) closure and pulmonary embolism management, this session reviews device-related thrombus, implant healing with novel coatings, and compares mechanical thrombectomy to catheter-directed thrombolysis. It also discusses the prognostic impact of hemodynamic data post-thrombectomy to inform clinical outcomes.
Innovative strategies in STEMI management
22 May 2026 – From EuroPCR 2026
This session presents innovative strategies in STEMI management, including the treatment of acute saphenous vein graft occlusion, primary PCI via the left internal mammary artery, and a two-step lesion debulking approach. It also covers hybrid drug-coated balloon strategies in complex multivessel disease and the emerging role...
Atypical NSTEMI culprit lesions
22 May 2026 – From EuroPCR 2026
Focusing on atypical NSTEMI culprit lesions, this session examines rare presentations such as calcific emboli, coronary anomalies, and unusual routes to revascularisation. It provides clinical insights into diagnosing and managing uncommon acute coronary syndromes effectively.